Literature DB >> 33689117

The Association Between Panel Size and Health Outcomes of Patients with Hypertension in Urban China: a Population-Based Retrospective Cohort Study.

Rize Jing1,2, Elham Mahmoudi3, Xiaozhen Lai1,2, Haijun Zhang1,2, Hai Fang4,5,6.   

Abstract

BACKGROUND: There is a paucity of evidence regarding the association between family physicians' panel size and health outcomes of patients with hypertension in China.
OBJECTIVE: To examine the association between family physicians' panel size and health outcomes of patients with hypertension in urban China.
DESIGN: This retrospective cohort study during 1 contract year from July 1, 2018, to June 31, 2019, was set in four community health centers (CHCs) in Xiamen City, China. PARTICIPANTS: A total of 18,119 adult patients (18+) diagnosed with hypertension and their 61 family physicians were included. MAIN MEASURES: Family physicians' panel size was measured by the number of registered patients in the preceding 6 months. The outcome measures included blood pressure (BP) control rate, systolic blood pressure (SBP), diastolic blood pressure (DBP), and mean arterial pressure (MAP) measured at each follow-up visit. KEY
RESULTS: Every additional 100 patients to the panel size were associated with an average of 17% increase in BP control rate (95% confidence interval [CI] = 1.15 to 1.19), and decrease in SBP (- 0.3 mmHg, 95% CI: - 0.38 to - 0.30), DBP (- 0.4 mmHg, 95% CI: - 0.39 to - 0.34), and MAP (- 0.4 mmHg, 95% CI: - 0.38 to - 0.33). After entering the quadratic term of panel size in the model, the panel size was negatively associated with BP control rate and positively associated with SBP, DBP, and MAP, while for the quadratic term, the odds ratio for BP control rate was positive and the coefficients for SBP, DBP, and MAP were negative. A U-shape association was found between panel size and health outcomes of patients with hypertension, and the turning point was about 600 patients.
CONCLUSIONS: The panel size of family physicians was curvilinearly associated with health outcomes of patients with hypertension in urban China.
© 2021. Society of General Internal Medicine.

Entities:  

Keywords:  China; family physicians; health outcomes; hypertension; panel size

Mesh:

Year:  2021        PMID: 33689117      PMCID: PMC8606355          DOI: 10.1007/s11606-021-06681-0

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  32 in total

1.  Is there time for management of patients with chronic diseases in primary care?

Authors:  Truls Østbye; Kimberly S H Yarnall; Katrina M Krause; Kathryn I Pollak; Margaret Gradison; J Lloyd Michener
Journal:  Ann Fam Med       Date:  2005 May-Jun       Impact factor: 5.166

2.  Provider practice characteristics that promote interpersonal continuity.

Authors:  Tyler S Mittelstaedt; Motomi Mori; William E Lambert; John W Saultz
Journal:  J Am Board Fam Med       Date:  2013 Jul-Aug       Impact factor: 2.657

Review 3.  Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

Authors:  Dena Ettehad; Connor A Emdin; Amit Kiran; Simon G Anderson; Thomas Callender; Jonathan Emberson; John Chalmers; Anthony Rodgers; Kazem Rahimi
Journal:  Lancet       Date:  2015-12-24       Impact factor: 79.321

4.  Effect of number of clinics and panel size on patient continuity for medical residents.

Authors:  Maureen D Francis; Whitney E Zahnd; Andrew Varney; Steven L Scaife; Mark L Francis
Journal:  J Grad Med Educ       Date:  2009-12

5.  The effect of physician panel size on health care outcomes.

Authors:  Theodore Stefos; James F Burgess; Michael F Mayo-Smith; Kathleen L Frisbee; Henry B Harvey; Laura Lehner; Sophie Lo; Eileen Moran
Journal:  Health Serv Manage Res       Date:  2011-05

6.  Are family practice trainers and their host practices any better? Comparing practice trainers and non-trainers and their practices.

Authors:  Pieter van den Hombergh; Saskia Schalk-Soekar; Anneke Kramer; Ben Bottema; Stephen Campbell; Jozé Braspenning
Journal:  BMC Fam Pract       Date:  2013-02-21       Impact factor: 2.497

7.  Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study.

Authors:  José R Banegas; Esther López-García; Jean Dallongeville; Eliseo Guallar; Julian P Halcox; Claudio Borghi; Elvira L Massó-González; Francisco J Jiménez; Joep Perk; Philippe Gabriel Steg; Guy De Backer; Fernando Rodríguez-Artalejo
Journal:  Eur Heart J       Date:  2011-04-06       Impact factor: 29.983

8.  Evaluation of the three-in-one team-based care model on hierarchical diagnosis and treatment patterns among patients with diabetes: a retrospective cohort study using Xiamen's regional electronic health records.

Authors:  Xuejun Li; Zhibin Li; Changqin Liu; Junfeng Zhang; Zhonghai Sun; Yuji Feng; Jing Mei; Chengming Gu; Xiaoying Li; Shuyu Yang
Journal:  BMC Health Serv Res       Date:  2017-11-28       Impact factor: 2.655

Review 9.  Quality of primary health care in China: challenges and recommendations.

Authors:  Xi Li; Harlan M Krumholz; Winnie Yip; Kar Keung Cheng; Jan De Maeseneer; Qingyue Meng; Elias Mossialos; Chuang Li; Jiapeng Lu; Meng Su; Qiuli Zhang; Dong Roman Xu; Liming Li; Sharon-Lise T Normand; Richard Peto; Jing Li; Zengwu Wang; Hongbing Yan; Runlin Gao; Somsak Chunharas; Xin Gao; Raniero Guerra; Huijie Ji; Yang Ke; Zhigang Pan; Xianping Wu; Shuiyuan Xiao; Xinying Xie; Yujuan Zhang; Jun Zhu; Shanzhu Zhu; Shengshou Hu
Journal:  Lancet       Date:  2020-06-06       Impact factor: 79.321

10.  Factors Associated with Family Physician Follow-up 30 Days Post-discharge from a Local Canadian Community Emergency Department.

Authors:  Kelly Lien; Barrett A Grattan; Alexandra L Reynard; Jocelynn Peters; Jennifer L Parr
Journal:  Cureus       Date:  2020-02-16
View more
  1 in total

1.  Satisfaction of Township Hospitals Health Workers on How They Are Paid in China.

Authors:  Beibei Yuan; Yahang Yu; Hongni Zhang; Huiwen Li; Chen Kong; Wei Zhang
Journal:  Int J Environ Res Public Health       Date:  2021-11-15       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.